Peipei Li

Dr. Peipei Li


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
PLPeipei Li
Peipei Li
ZZZhini Zhu
Zhini Zhu
YWYong Wang
Yong Wang
XZXuyuan Zhang
Xuyuan Zhang
CYChuanhui Yang
Chuanhui Yang
QQQianhui Qu
Qianhui Qu
Thiamine and pyridoxine are essential B vitamins that serve as enzymatic cofactors in energy metabolism, protein and nucleic acid biosynthesis, and neurotransmitter production. In humans, thiamine transporters SLC19A2 and SLC19A3 primarily regulate cellular uptake of both vitamins. Genetic mutations in these transporters, which cause thiamine and pyridoxine deficiency, have been implicated in severe neurometabolic diseases. Additionally, various prescribed medicines, including metformin and fedratinib, manipulate thiamine transporters, complicating the therapeutic effect. Despite their physiological and pharmacological significance, the molecular underpinnings of substrate and drug recognition remain unknown. Here we present ten cryo-EM structures of human thiamine transporters SLC19A3 and SLC19A2 in outward- and inward-facing conformations, complexed with thiamine, pyridoxine, metformin, fedratinib, and amprolium. These structural insights, combined with functional characterizations, illuminate the translocation mechanism of diverse chemical entities, and enhance our understanding of drug-nutrient interactions mediated by thiamine transporters.

3 June 2022 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
XLXing Li
Xing Li
LZLingpu Zhang
Lingpu Zhang
TLTuo Li
Tuo Li
SLShumu Li
Shumu Li
WWWenjing Wu
Wenjing Wu
ZZZhenwen Zhao
Zhenwen Zhao
Background: Cisplatin, the alkylating agent of platinum(II) (Pt(II)), is the most common antitumor drug in clinic; however, it has many side effects, therefore it is higly desired to develop low toxicity platinum(IV) (Pt(IV)) drugs. Multi-omics analysis, as a powerful tool, has been frequently employed for the mechanism study of a certain therapy at the molecular level, which might be helpful for elucidating the mechanism of platinum drugs and facilitating their clinical application. Methods: Strating form cisplatin, a hydrophobic Pt(IV) prodrug (CisPt(IV)) with two hydrophobic aliphatic chains was synthesized, and further encapsulated with a drug carrier, human serum albumin (HSA), to form nanoparticles, namely AbPlatin(IV). The anticancer effect of AbPlatin(IV) was investigated in vitro and in vivo. Moreover, transcriptomics, metabolomics and lipidomics were performed to explore the mechanism of AbPlatin(IV). Results: Compared with cisplatin, Abplatin(IV) exhibited better tumor-targeting effect and greater tumor inhibition rate. Lipidomics study showed that Abplatin(IV) might induce the changes of BEL-7404 cell membrane, and cause the disorder of glycerophospholipids and sphingolipids. In addition, transcriptomics and metabolomics study showed that Abplatin(IV) significantly disturbed the purine metabolism pathway. Conclusions: This research highlighted the development of Abplatin(IV) and the use of multi-omics for the mechanism elucidation of prodrug, which is the key to the clinical translation of prodrug. Graphical

30 June 2023 in Neuroscience Bulletin
Verified
Journal Article
Closed access
PDF file
YZYuan Zhang
Yuan Zhang
FYFanglei Ye
Fanglei Ye
XFXiaolong Fu
Xiaolong Fu
SLShen Li
Shen Li
LWLe Wang
Le Wang
PLPeipei Li
Peipei Li

14 March 2025 in International Immunopharmacology
Verified
Journal Article
Open access
DLDuopin Li
Duopin Li
YSYan Shi
Yan Shi
QFQi Feng
Qi Feng
FTFei Tian
Fei Tian
YZYilin Zhang
Yilin Zhang
ZLZhangsuo Liu
Zhangsuo Liu
Membranous nephropathy (MN) is the main type of adult nephrotic syndrome, and its prevalence is increasing annually. An increasing number of studies have suggested that the pathogenesis of MN is related to 2.5-μm particulate matter (PM2.5), but the underlying mechanism has not been elucidated fully. Elucidating this mechanism can help prevent and treat MN. The constituents of PM2.5 vary from place to place; hence, the component responsible for PM2.5-related MN is still unclear. This study investigated the effects of benzo[b]fluoranthene (BbF), a PM2.5 component, on pyroptosis and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signalling pathway in Sprague-Dawley rats and mouse podocytes. The organic constituents of BbF in PM2.5 can enter the circulatory system through the lungs and act on the kidneys to cause kidney damage, possibly because BbF activates the PI3K/AKT pathway and causes podocytes to undergo pyroptosis.

8 October 2025 in Human Molecular Genetics
Verified
Journal Article
Closed access
PLPeipei Li
Peipei Li
TZTing Zhang
Ting Zhang
HXHongen Xu
Hongen Xu
MZMengwei Zhao
Mengwei Zhao
YWYingying Wang
Yingying Wang
BCBei Chen
Bei Chen
Variants in the SLC52A3 gene have been associated with riboflavin transporter deficiency type 3 (RTD3), a severe neurodegenerative disorder, typically inherited in an autosomal recessive manner. In this study, two SLC52A3 variants (NM_033409.4: c.62A > G [p.Asn21Ser] and c.161G > A [p.Gly54Glu]) were identified in a family with hereditary hearing loss through whole-exome sequencing. The compound heterozygous proband exhibited only late-onset, progressive, and symmetric sensorineural hearing loss over 23 yr, along with unilateral facial muscle spasm. A heterozygous carrier of the c.62A > G variant also exhibited optic nerve dysfunction, while no other neurological abnormalities were observed in the family. Although the proband’s decreased serum riboflavin level has been improved through supplementation, no significant clinical improvement was observed. These findings further support the phenotypic variability, incomplete penetrance, and a potential autosomal dominant inheritance pattern of RTD3. We also underscore the importance of early genetic testing, timely and sustained riboflavin supplementation, and long-term follow-up in affected individuals.

1 June 2026 in Sensory Neuroscience
Verified
Journal Article
Open access
YZYuan Zhang
Yuan Zhang
SLShen Li
Shen Li
YZYangfan Zhou
Yangfan Zhou
DLDuopin Li
Duopin Li
JDJunru Ding
Junru Ding
PLPeipei Li
Peipei Li
Hearing loss is the most common disabling disease among humans, which adversely affects human health. Sensorineural hearing loss (SNHL) accounting for approximately 63% of all hearing loss cases. SNHL may be classified into age‐related hearing loss (ARHL), drug‐induced hearing loss (DIHL), noise‐induced hearing loss (NIHL), and sudden sensorineural hearing loss (SSHL). Up to now, there are some recognized theories of SNHL, mainly including oxidative stress theory, vascular damage theory, and metabolic damage theory. However, the mechanism of SNHL has not yet been fully elucidated due to the highly complex etiologies, pathogenic mechanisms, and pathogenic changes in various types of hearing loss. In addition, the clinical treatment of SNHL is also varied. It mainly includes drug therapy, gene therapy, cochlear implantation, and so on. However, in view of the complex pathogenesis of SNHL, it is still insufficient to find precise and individualized treatment strategies. In this review, we thoroughly elucidate the classification and various pathogenesis of SNHL and introduce various treatment strategies for SNHL in detail, in order to provide scientific evidence for understanding the pathological process of SNHL and rational application of SNHL treatment.